COVID-19 & antiepileptic drugs: Should we pay attention?

Seizure. 2020 Aug:80:240-241. doi: 10.1016/j.seizure.2020.07.005. Epub 2020 Jul 7.

Authors

Oguzhan Fırat¹, Nadir Yalçın², Kutay Demirkan²

Affiliations

¹ Hacettepe University, Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkey. Electronic address: [email protected].
² Hacettepe University, Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkey.

No abstract available

Publication types

Letter

MeSH terms

Anticonvulsants / adverse effects*
Antiviral Agents / adverse effects*
Atazanavir Sulfate / adverse effects
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Carbamazepine / adverse effects
Coronavirus Infections / complications
Coronavirus Infections / drug therapy*
Drug Combinations
Drug Interactions
Humans
Lopinavir / adverse effects
Pandemics
Phenytoin / adverse effects
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy*
Ritonavir / adverse effects
SARS-CoV-2
Seizures / drug therapy*
Seizures / etiology

Substances

Anticonvulsants
Antiviral Agents
Drug Combinations
lopinavir-ritonavir drug combination
Lopinavir
Carbamazepine
Atazanavir Sulfate
Phenytoin
Ritonavir